Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excellarate in non-healing diabetic foot ulcers
NCT00493051Phase 2Completed
- Sponsor
- Tissue Repair Ltd
- Start
- Nov 2007
- Primary completion
- Dec 2009
- Modality
- Gene Editing, Injectable Hydrogels, Implantable Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GAM501 in diabetic foot ulcer (DFU), sponsored by Tissue Repair Ltd. Started Nov 2007; status: completed.
02
Drugs
GAM501
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00493051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493051.